Cytogenetic studies in children with Acute Lymphocitic Leukemia-B in Costa Rica;Estudios citogenéticos en niños con Leucemia Linfocitica Aguda-B en Costa Rica

Revista de Biologia Tropical

Volumn 52, Issue 3, 2004, Pages 551-558

  Venegas, Patricia ^a   Rivera, Julio ^a  

^a Caja Costarricense del Seguro Social   (Costa Rica)

Author keywords

Acute Lymphocytic leukemia; Chromosomal abnormalities; Costa Rica; Cytogenetics; Prognostic factors

Indexed keywords

ARTICLE; B CELL LEUKEMIA; BONE MARROW; CHILD; CHROMOSOME ABERRATION; COSTA RICA; GENETICS; HUMAN; KARYOTYPING; METHODOLOGY; PATHOLOGY; PROGNOSIS;

BONE MARROW; CHILD; CHROMOSOME ABERRATIONS; COSTA RICA; HUMANS; KARYOTYPING; LEUKEMIA, B-CELL, ACUTE; PROGNOSIS;

EID: 21044437580     PISSN: 00347744     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Andreasson, P., M. Hoglund, A.N. Bekassy, S. Garwicz, J. Heldrup, F. Mitelman & B. Johansson. 2000. Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias.Eur. J. Haematol.65: 40-51.
2. Alter, D. & H.F. Mark. 2000 Cytgenetics study of a patient with acute lymphobalstic leukemia using GTG-banding and chromosome painting. Exp. Mol. Pathol. 69: 152-158.
3. Bhatia, S., H.N. Sather, N.A. Heerema, M.E. Trigg, P.S. Gaynon & L.L. Robison. 2002. Racial and ethnic differences in survival of Children with acute lymphoblastic leukemia. Blood 100: 1957-1964.
4. Boomer, T., M. Varella-Garcia, L. McGavran, L. Meltesen, A.S. Olsen & S.P. Hunger. 2001. Detection of E2A translocation in leukemias via fluorecense in situ hibridization. Leukemia 15: 95-102.
5. Castro Volio, I., C. Montera & G. Jiménez. 1993. Características cromosómicas asociadas con leucemias y otras hematopatías en Costa Rica. Rev. Biol. Trop. 41: 385-392.
6. Castro Volio, I. 2004. Pasado, presente y future de la citogenética humana en Costa Rica. Rev. Biol. Trop. 52: 133-140.
7. Chaves-Villalobos M., G. Jiménez-Arce, M. Sandí- Díaz. 2004. Polimorfismo del gen de la banda 3 eritrocítica en grupos étnicos de Costa Rica. Rev. Biol. Trop. 52(3): 255-259.
8. Dower, D. 2003. The epidemiology of Acute promyelocitic Leukemia: Best Pract Res Clin. Haematol. 16: 357-367.
9. Forestier, E., B. Johansson, G. Borgstrom, G. Kerndrup, J. Johansson & S. Heim. 2000. Cytogenetics finding in a population-based series of 787 childhood acute lymphoblastic leukemias from the Nordic Countries. The NOPHO Leukemia Cytogenetic study.Group. Eur. J. Haematol. 64: 194-200.
10. GFCH. 1993. Groupe Francais de Cytogenetique Hematologique: collaborative study of Karyotypes in childhood acute lymphoblastic leukemias. Leukemia 7: 10-19.
11. Gisselbrecht, S. 2003. Oncogenes and leukemia: history and perspectives. Med. Sci. (Paris). 19: 201-210.
12. Harrison, C.J. 2001. The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia. 15: 49-59.
13. Hyakuna, N., Y. Kaneko, N. Katano, T. Iwai, T. Nagata, K. Sakashita, O. Takeda, A. Tanaka, H. Azuma, I. Sekine & T. Fujimoto. 2000. Prognosis significance of chromosome análisis in childhood acute lymphoblastic leukemia.Children s cancer and leukemia study group (CCLSG). 41: 576-584.
14. ISCN. 1995. An International Sytem for Human Cytogenetic Nomenclature. Basel Karger, pp. 1-114.
15. Jarosova, M., M. Holzerova, K. Jedlickova, V. Mihal, J. Zuna, J. Stary, D. Pospisilova, Z. Zemanova, J. Trka, J. Blazek, Z. Pikalova & K. Indrak. 2000. Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemia. Cancer Genet. Cytogenet. 123: 114-122.
16. Jiménez Bonilla, R. 2004. Historia de la investigación de la leucemia en Costa Rica. Rev. Biol. Trop. 52: 155-165.
17. Koning, M., M. Reichel, R. Marschalex, O.A. Haas & S. Strehl. 2002. A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukaemias. Br. J. Haematol. 116: 758-764.
18. Kurzrock, R., H.M. Kantarjian, B.J. Druker & M. Talpaz. 2003. Philadelphia Chromosome-positive leukemias:from basic mechanisms to molecular therapeutics. Ann. Intern. Med. 138(10): 819-830.
19. Maloney, K., L. McGavran, J. Murphy, L. Odom, L. Stork, Q. Wei & S Hunger. 1999. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have excellent prognosis when a treated with therapy that includes a single delayed intensification. Leukemia 13: 1708-1712.
20. Lu, X.Y., C.P. Harris, L. Cooley, J. Margolin, P.C. Steuber, M. Sheldon, P.H. Rao, C.C. Lau. 2002. The utility of spectral Karyoting in the cytogenetic analysis of newly diagnosed pediatric acute lymphoblastic leukemia.Leukemia 16: 2222-2227.
21. Ma, S.K., T.S. Wan & L.C. Chan. 1999. Cytogenetics and molecular genetics of Childhood leukemia. Hematol. Oncol. 17(3): 91-1058.
22. Martín Ramos, M., F. Fernández Martínez & E. Barreiro Miranda. 2001. Cytogenetic abnormalities in acute lymphoblastic leukemia. An. Esp. Pediatr. 55(1): 45-52.
23. Martínez-Ramírez, A., M. Urioste, T. Contra, A. Cantalejo, A. Tavares, J.A. Portero, B. Lopez-Ibor, M. Bernacer, C. Soto, J.C. Cigudosa & J. Benitez. 2001. Fluoresence in situ hybridization study of TEL/AMLfusion and other abnormalities involving TEL and AML genes.Correlation with Cytogenetic finding and prognostic value in children with acute lymphoblastic leukemia. Haematologica 86: 1253-1254.
24. Mathew, S., P.H. Rao, J. Dalton, J.R. Downing & S.C. Raimondi. 2001. Multicolor spectral karyotyping identifies novel translocations in childhood acute lymphoblastic leukemia. Leukemia 15: 468-472.
25. Morera, B., R. Marín-Rojas & R. Barrantes. 2001. Análisis de varios marcadores genéticos clásicos en la población de Costa Rica. Rev. Biol. Trop. 49: 1237-1252.
26. Morera, B., R. Marín-Rojas & R. Barrantes. 2003. Gene Admixture in the Costa Rican Population. Ann. Hum. Genet. 67: 71-80.
27. Nordgren, A., M. Heyman, S. Sahlen, J. Schoumans, S. Soderhall, M. Nordenskjold & E. Blennow. 2002. Spectral Karyotyping and intephase FISH reveal abnormalities not detected by conventional G-banding.Implications for treatment stratification of Childhood acute lympholastic leukemia: detailed analysis of 70 cases. Eur. J. Haematol. 68: 31-41.
28. Patel, A.S., A.L. Hawkins & C.A. Griffin. 2000. Cytogenetics and cancer. Curr. Opin. Oncol. 12: 62-67.
29. Perez-Vera, P., M. Mujica-Sanchez, A. Carnevale, R. Rivera-Luna, R. Paredes, A. Martinez & Frias. 2001. Cytogenetic in acute lymphoblastic leukemia in Mexican Children: an Institutional experience. Arch. Med. Res. 32: 202-207.
30. Pui, C.-H., W.M. Crist & T. Look. 1990. Biology and Clinical Significance of Cytogenetic Abnormalities in Childhood Acute Lymphoblastic Leukemia. Blood 76: 1449-1463.
31. Raimondi, S.C., P.K. Roberson, C.H. Pui, F.G. Behm & G.K. Rivera. 1992. Hyperdiploid (47-50) acute lymphoblastic leukemia in children. Blood 79: 3245-3252.
32. Raimondi, S.C., C.H. Pui, M.L. Hancock, F.G. Behm, L. Filatov & G.K. Rivera. 1996. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia 10: 213-224.
33. Rubin, C.M. & M.M. Le Beau. 1991. Cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Am. J. Pediatr. Hematol. Oncol. 13: 202-216.
34. Rutherford, M.N., G.R. Bayly, B.P. Matthews, T. Okuda, W.M. Dinjens, H. Kondoh & D.P. LeBrun. 2001.The leukemogenic transcription factor E2a-Pbx1 induced expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells. Leukemia 15: 362-370.
35. Sattler, M., B Scheijen, E. Weisberg & J.D. Griffin. 2003. Mutated tyrosine Kinases as therapeutic targets in myeloid leukemia. Adv. Exp. Med. Biol. 532: 121-140.
36. Secker-Walker, L.M. 1998. on behalf of the European 11q23 Worshop Partricipants. General Report on the European Union Concerted Action Workshop on 11q23. Leukemia 12: 776-778.
37. Silva, M.L., M.H. Ornellas de Souza, R.C. Ribeiro, M.G. Land, A.M. Boulhosa de Azevedo, F. Vasconcelos, L. Otero, Z. Vasconcelos, L.F. Bouzas & E.Abdelhay. 2002.Cytogenetic Analyisis of 100 consecutive newly diagnosed cases of Acute Lymphoblastic Leukemia in Rio de Janeiro. Cancer Genet. Cytogenet. 137: 85-90.
38. Smith, M.A., L.A.G. Ries, J.G. Gurney & J.A. Ross. 1999. Leukemia. In L.A.G. Ries, M.A. Smith, J.G. Gurney, M. Linet, T. Tamra, J.L. Young, & G.R. Bunin, (eds.). Cancer Incidence and Survival Among Children and Adoldescents:United States SEER Program 1975-1995. Bethesda Md: Cancer Statistics Branch, Cancer Surveillance Research Program, Division of Cncer Control and Population Sciences, National Cancer Instituve. pp. 17-34.
39. Solís, V., M. de los A. Alvarado, E. Ruiz, J. Carrillo, M. Navarrete, G. Sánchez & E. Jiménez. 2000. Citogenética y citoquímica de pacientes con leucemia en dos hospitales neotropicales. Rev. Biol. Trop. 48: 707-718.
40. Third International Worshop on chromosome in Leukemia. 1981. Chromosome in Leukemia.Cromosomal Abnormalities in acute Lymphoblastic leukemia. Cancer. Genet. Cytogenet. 4: 101-110.
41. Thirman, M.J., H.J. Gill, R.C. Burnett, et al. 1993. Rearrangement of MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocatios. N. Engl. J. Med. 329: 909-914.
42. Uckun, F.M., M.G. Sensel, H.N. Sather, P.S. Gaynon, D.C. Arthur, B.J. Lange, P.G. Steinherz, P. Kraft, R. Hutchinson, J.B. Nachman, G.H. Reaman & N.A. Heerema. 1998. Clinical Significance of translocation t(1;19) in a childhood acute lymphoblastic leukemia in the context of comterporay therapies: a report from the children s cancer group. J. Clin. Oncol. 16: 527-535.
43. van der Plas, D.C., K. Kahlen & A. Hagemeijer. 1992. Prognostic significance of karyotype at diagnosis in childhood acute lymphoblastic leukemia. Leukemia 6: 176-184.
44. Venegas, P. 2001a. Interfase-FISH en un paciente con leukemia mielocítica crónica. Rev. Méd. Hosp. Nac. de Niños. 36: 9-13.
45. Venegas, P. 2001b. Translocacion t(4;11) de infantes con leucemia linfocítica aguda. Rev. Méd. Hosp. Nac. Niños. 36: 5-8.
46. Wu, S.Q., K.I. Weinberg, W.J. Joo, J.J. Quinn, J. Franklin, S.E. Siegel & P.S. Gaynon. 2003. Preponderant mitotic activity of nonleukemic cells plays an imprtant role in failures to detect abnormal clone in childhood acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 25: 520-525.
47. Zemanova, Z., K. Michalova, J. Brezinova, L. Sindelarova, S. Kurkova, P. Smisek, J. Zuna, J. Trka & J. Stary. 2001. Fluorescent in situ Hybridization (FISH) in the diagnosis of acute childhood lymphatic leukemia (ALL). Cas. Lek. Cesk. 140: 519-524.